Search

Displaying results 6551 - 6560 of 8010 in total
  1. Drug

    Idrocilamide

    go.drugbank.com/drugs/DB13297
    Experimental

    Categories: Topical Products for Joint and Muscular Pain
  2. Drug

    Tibezonium iodide

    go.drugbank.com/drugs/DB13702
    Experimental

    Categories: Antiinfectives and Antiseptics for Local Oral Treatment
  3. Drug

    Mito-4509

    go.drugbank.com/drugs/DB05846
    Experimental

    Mito-4509 is a non-feminizing estrogen analog that could affect mitochondrial metabolic pathways. It is used to treat Parkinson's Disease, Alzheimer's Disease, Retinal Disorders and other neurologic Disorders.

  4. Drug

    Megestrol

    go.drugbank.com/drugs/DB19378
    Approved

    Categories: Hormonal Contraceptives for Systemic Use
  5. Drug

    Roxarsone

    go.drugbank.com/drugs/DB11458
    ExperimentalVet approved

    The drug is also approved in the United States for use in pigs.

    International brands: Ren-O-Sal
  6. Drug

    AEM-28-14

    go.drugbank.com/drugs/DB17643
    Experimental

    [L45909] It is being investigated for lipid disorders such as homozygous familial hypercholesterolemia.[L45914]

  7. Drug

    Pegsitacianine

    go.drugbank.com/drugs/DB19098
    Investigational

    under investigation in clinical trial NCT05576974 (A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for

  8. Drug

    Phenoxybenzamine

    go.drugbank.com/drugs/DB00925
    ApprovedInvestigational

    An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

  9. Drug

    Clopamide

    go.drugbank.com/drugs/DB13792
    Investigational

    Like thiazide diuretics, it has an aromatic sulfonamide base but with no double-ring structure.

  10. Drug

    Icalcaprant

    go.drugbank.com/drugs/DB21651
    Investigational

    The usage of the INN stem '-caprant' in the name indicates that Icalcaprant is a kappa-opioid receptor (KOR) antagonist. … Icalcaprant is under investigation in clinical trial NCT06696755 (A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder